Lidocaine Infusion and Neurophysiological Monitoring in Scoliosis Surgery

A supplemental analysis of a prospective study, published by Wiley Online Library, examines how intraoperative lidocaine infusion therapy interacts with neurophysiological monitoring in adolescents undergoing surgical correction of idiopathic scoliosis.

The study population is adolescent idiopathic scoliosis patients. The intervention under scrutiny is intravenous lidocaine administered during the operation. The monitoring context is intraoperative neurophysiology — the standard of care for spine deformity correction, where somatosensory and motor evoked potentials alert the surgical team to impending neurological injury.

That combination matters. Lidocaine, a sodium-channel blocker, suppresses neuronal excitability. Evoked-potential amplitude depends on precisely that excitability. A systemic infusion given during instrumentation could, in principle, blunt the signals the monitoring team relies on to detect cord compromise.

What does the analysis address?

The paper is a supplemental analysis, not the primary endpoint report of the parent prospective study. This framing tells readers two things: the parent trial collected its data prospectively under a predefined protocol, and this paper re-examines that dataset to answer a secondary question about monitoring.

For clinical neurophysiologists, the operative questions are concrete:

• Does an intraoperative lidocaine infusion measurably alter evoked-potential amplitude or latency in this adolescent cohort?
• Can monitoring thresholds and alarm criteria remain reliable while the infusion runs?
• Are dose or timing adjustments needed to preserve signal integrity through the correction and instrumentation phases?

The Wiley record does not yet disclose the full numerical results, cohort size, or effect sizes; readers should treat this article as the publication announcement and consult the full text for the study's figures and statistical conclusions.

Why adolescent scoliosis cases are the testing ground

Idiopathic scoliosis correction in adolescents is among the highest-volume surgeries that mandate multimodal intraoperative neurophysiological monitoring. Posterior spinal fusion with segmental instrumentation places the spinal cord at mechanical risk during correction maneuvers. Monitoring teams typically track somatosensory evoked potentials continuously and transcranial motor evoked potentials at critical stages, with neuromuscular blockade and anesthetic depth tightly controlled to keep signals interpretable.

Any drug added to that regimen gets scrutinized for its effect on the monitoring chain. Lidocaine infusions are used intraoperatively for analgesia and opioid-sparing effects, so the interaction question is not hypothetical — it arises whenever an anesthesia team runs the infusion during a monitored spine case.

What this means for the reading room and the monitoring suite

The clinical relevance is practical. Intraoperative monitoring teams increasingly encounter patients receiving adjunct infusions — lidocaine among them — and must decide whether a signal change reflects neurological compromise or pharmacological suppression. A prospective dataset in adolescents directly addresses that ambiguity for this drug class.

If the supplemental analysis shows preserved evoked-potential reliability under the infusion, anesthesia teams gain freedom to continue opioid-sparing adjuncts without additional monitoring burdens. If it shows signal attenuation, monitoring protocols may need infusion timing rules — pausing lidocaine during correction maneuvers or adjusting alarm thresholds accordingly.

Where the evidence sits

This is a prospective human study in an adolescent surgical cohort, published in the peer-reviewed literature — not an animal experiment, not a device trial, and not a retrospective chart review. The supplemental-analysis designation means its conclusions carry the weight of prospective data collection but answer a secondary question, and readers should weigh the findings in that context.

The full publication, available through Wiley Online Library, will specify the monitoring modalities used, the infusion protocol, and the outcome measures. Teams running monitored scoliosis corrections should watch for the detailed results, as they will determine whether intraoperative lidocaine earns a place in — or a caution label for — the standard multimodal monitoring plan.